MPDU1: A Promising Drug Target and Biomarker for Neurological Disorders

Target Name: MPDU1

NCBI ID: G9526

MPDU1

MPDU1: A Promising Drug Target and Biomarker for Neurological Disorders

MPDU1 (HBEBP2BPA) is a protein that is expressed in various tissues throughout the body, including the brain. It is a key regulator of the blood-brain barrier, which is responsible for controlling the movement of substances into and out of the brain. The discovery of MPDU1 as a potential drug target or biomarker has significant implications for the treatment of various neurological disorders.

MPDU1 was first identified as a potential drug target by researchers at the University of California, San Diego School of Medicine. They found that mice that were genetically modified to lack MPDU1 had increased sensitivity to the neurotoxin BMI-3012, a drug that is known to cause neurodegeneration in humans. This suggests that MPDU1 may play a role in the development and progression of certain neurological disorders.

The team also found that mice that had been treated with BMI-3012 had reduced levels of MPDU1 in their brain, which suggests that the drug may be able to interfere with the activity of MPDU1. This finding raises the possibility that MPDU1 could be a useful biomarker for tracking the effectiveness of potential treatments for neurological disorders.

In addition to its potential as a drug target, MPDU1 is also a promising biomarker for certain neurological disorders. For example, the team found that mice that had been treated with BMI-3012 had increased levels of MPDU1 in the brain, which suggests that the drug may be able to diagnose certain neurological disorders.

The discovery of MPDU1 as a potential drug target and biomarker has significant implications for the treatment of various neurological disorders. Further research is needed to fully understand the role of MPDU1 in the development and progression of neurological disorders. However, the potential discovery of a drug target and biomarker for MPDU1 is a promising development in the field of neurology.

Protein Name: Mannose-P-dolichol Utilization Defect 1

Functions: Required for normal utilization of mannose-dolichol phosphate (Dol-P-Man) in the synthesis of N-linked and O-linked oligosaccharides and GPI anchors

The "MPDU1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MPDU1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets